PRAX
Praxis Precision Medicines, Inc.
NASDAQ · Healthcare · Biotechnology · US
$260.17
+7.61%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 47.97x
- P/S forward
- 48.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.42x
- Price / sales
- —
- Price / cash flow
- -23.76x
Enterprise value
- Enterprise value
- $6.5B
- EV / sales
- —
- EV / EBITDA
- -19.19x
- EV / EBIT
- -17.21x
- Market cap
- $7.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026